| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2006;29:579-584
© 2006 Elsevier Science NL
a Division of Thoracic Surgery, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland
b Division of Oncology, University Hospital Zurich, Switzerland
c Institute for Biostatistics and Preventive Medicine, Switzerland
Received 23 September 2005; received in revised form 26 December 2005; accepted 10 January 2006.
* Corresponding author. Tel.: +41 44 255 8802; fax: +41 44 255 8805. (Email: walter.weder{at}usz.ch).
Objective: To investigate the incidence and management of postoperative complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Methods: Patients with histologically proven mesothelioma of clinical stages T1–3, N0–2, M0 and considered to be completely resectable received neoadjuvant chemotherapy (cisplatin + gemcitabine or cisplatin + pemetrexed) followed by extrapleural pneumonectomy and postoperative radiotherapy. The incidence and management of postoperative complications in general and of bronchopleural fistula and postpneumonectomy-empyema in particular were analyzed. Univariate analysis was performed to identify prognostic factors [sex, age, side of operation, weight loss, smoking, chemotherapy, EORTC-score (European Organization for Research and Treatment of Cancer-classification) and duration of operation]. Results: Between 1st May 1999 and 15th August 2005, 63 patients underwent complete extrapleural pneumonectomy after neoadjuvant chemotherapy. Postoperative complications were observed in 39 cases (62%) and 2 patients died within 30 days (3.2%). Postpneumonectomy-empyema occurred in 15.8% of the patients (n = 10), six with a bronchopleural fistula on the right side. All empyemas were treated successfully. Five patients developed chylothorax (7.9%) and four patients had complications due to a patch failure: cardiac herniation (n = 2), restriction of cardiac output (n = 1) or gastric herniation (n = 1). Patients with higher EORTC-score presented significantly more postoperative complications (p = 0.03). A longer duration of surgery tended to be associated with a higher incidence of postoperative complications, especially of empyemas. Conclusions: Extrapleural pneumonectomy after neoadjuvant chemotherapy can be performed with mortality rates comparable to standard pneumonectomies. Complications are frequent but can be successfully managed; the EORTC-score seems to be a predictor for postoperative complications.
Key Words: Extrapleural pneumonectomy • Complications • Neoadjuvant chemotherapy • Malignant pleural mesothelioma • EORTC-score
This article has been cited by other articles:
|
|
 |
|
  G. Buduhan, S. Menon, R. Aye, B. Louie, V. Mehta, and E. Vallieres Trimodality therapy for malignant pleural mesothelioma. Ann. Thorac. Surg., September 1, 2009; 88(3): 870 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Hamad, G. Marulli, F. Sartori, and F. Rea Pericardial flap for bronchial stump coverage after extrapleural pneumonectomy; is it feasible? Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1255 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Sorensen, J. Ravn, A. Loft, J. Brenoe, A. K. Berthelsen, and on behalf of the Nordic Mesothelioma Group Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 1090 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Aigner, M. A. R. Hoda, G. Lang, S. Taghavi, G. Marta, and W. Klepetko Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 204 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Perrot, K. McRae, M. Anraku, K. Karkouti, T. K. Waddell, A. F. Pierre, G. Darling, S. Keshavjee, and M. R. Johnston Risk Factors for Major Complications After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma Ann. Thorac. Surg., April 1, 2008; 85(4): 1206 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Rice, C. W. Stevens, A. M. Correa, A. A. Vaporciyan, A. Tsao, K. M. Forster, G. L. Walsh, S. G. Swisher, W. L. Hofstetter, R. J. Mehran, et al. Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma Ann. Thorac. Surg., November 1, 2007; 84(5): 1685 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 British Thoracic Society Standards of Care Committ BTS statement on malignant mesothelioma in the UK, 2007 Thorax, November 1, 2007; 62(Suppl_2): ii1 - ii19. [Full Text] [PDF]
|
|
|
|
|
|
T. F. Molnar Current surgical treatment of thoracic empyema in adults Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 422 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Ceresoli, C. Gridelli, and A. Santoro Multidisciplinary Treatment of Malignant Pleural Mesothelioma Oncologist, July 1, 2007; 12(7): 850 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Opitz, D. Lardinois, S. Arni, S. Hillinger, P. Vogt, B. Odermatt, V. Rousson, and W. Weder Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 772 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lucchi, A. Chella, F. Melfi, P. Dini, M. Ambrogi, L. Fino, G. Fontanini, and A. Mussi A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
